106 related articles for article (PubMed ID: 2080254)
41. Over expression of vascular endothelial growth factor in correlation to Ki-67, grade, and stage of breast cancer.
Al-Harris ES; Al-Janabi AA; Al-Toriahi KM; Yasseen AA
Saudi Med J; 2008 Aug; 29(8):1099-104. PubMed ID: 18690299
[TBL] [Abstract][Full Text] [Related]
42. [Flow cytometric analysis of Ki-67 reactive antigen].
Murakami T; Sasaki K; Takahashi M
Nihon Rinsho; 1992 Oct; 50(10):2355-9. PubMed ID: 1280305
[TBL] [Abstract][Full Text] [Related]
43. Proliferation of invasive breast carcinomas and colorectal adenocarcinomas: an immunohistochemical in situ investigation with the monoclonal antibody Ki-67.
Horny HP; Horst HA
Zentralbl Allg Pathol; 1988; 134(6):547-54. PubMed ID: 3213288
[TBL] [Abstract][Full Text] [Related]
44. [Immunohistochemical approach to reveal the growth potential of uterine cancers using anti-BrdU antibody and Ki-67].
Yoshinouchi M
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2513-21. PubMed ID: 2614188
[TBL] [Abstract][Full Text] [Related]
45. [Ki-67 antigen, a cell cycle and tumor growth marker].
Seigneurin D; Guillaud P
Pathol Biol (Paris); 1991 Dec; 39(10):1020-8. PubMed ID: 1666669
[TBL] [Abstract][Full Text] [Related]
46. [Cell sorting in flow cytometry].
Nishiya I
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Aug; 40(8):1056-62. PubMed ID: 3251962
[TBL] [Abstract][Full Text] [Related]
47. Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancer.
Pierga JY; Leroyer A; Viehl P; Mosseri V; Chevillard S; Magdelénat H
Breast Cancer Res Treat; 1996; 37(1):57-64. PubMed ID: 8750528
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical determination of growth fraction in human tumors.
Matsumura K; Tsuji T; Shinozaki F; Sasaki K; Takahashi M
Pathol Res Pract; 1989 Jun; 184(6):609-13. PubMed ID: 2780432
[TBL] [Abstract][Full Text] [Related]
49. Immunocytochemical staining of proliferating cells in endoscopically biopsied tissues of gastric carcinomas with monoclonal antibody Ki-67.
Yonemura Y; Kimura H; Ooyama S; Kamata T; Yamaguchi A; Matsumoto H; Ninomiya I; Miyazaki I
Oncology; 1991; 48(2):162-5. PubMed ID: 1997941
[TBL] [Abstract][Full Text] [Related]
50. Detection of Ki-67 proliferation rate in breast cancer. Correlation with clinical and pathologic features.
Veronese SM; Gambacorta M
Am J Clin Pathol; 1991 Jan; 95(1):30-4. PubMed ID: 1987749
[TBL] [Abstract][Full Text] [Related]
51. The correlation of growth fractions with histologic grading and lymph node status in human mammary carcinoma.
Lellé RJ; Heidenreich W; Stauch G; Gerdes J
Cancer; 1987 Jan; 59(1):83-8. PubMed ID: 2431758
[TBL] [Abstract][Full Text] [Related]
52. Correlation of growth fraction by Ki-67 immunohistochemistry with histologic factors and hormone receptors in operable breast carcinoma.
Gasparini G; Dal Fior S; Pozza F; Bevilacqua P
Breast Cancer Res Treat; 1989 Dec; 14(3):329-36. PubMed ID: 2482095
[TBL] [Abstract][Full Text] [Related]
53. Determination of proliferative fractions detected by immunohistochemistry with the monoclonal antibodies to bromodeoxyuridine and Ki-67 in malignant lymphomas.
Kawauchi K; Sato Y; Furuya T; Watanabe S
Hematol Oncol; 1989; 7(4):257-65. PubMed ID: 2472342
[TBL] [Abstract][Full Text] [Related]
54. Monoclonal antibody Ki-67: its use in histopathology.
Brown DC; Gatter KC
Histopathology; 1990 Dec; 17(6):489-503. PubMed ID: 2076881
[TBL] [Abstract][Full Text] [Related]
55. Immunohistochemical evaluation of growth fractions in human breast cancers using monoclonal antibody Ki-67.
Weikel W; Beck T; Mitze M; Knapstein PG
Breast Cancer Res Treat; 1991 Aug; 18(3):149-54. PubMed ID: 1756257
[TBL] [Abstract][Full Text] [Related]
56. Diagnostic implications of Ki-67 expression in adipocytes and lipoblasts: an immunohistochemical study.
Wang HJ; Li CY; Wang YK
Int J Clin Exp Pathol; 2014; 7(12):8899-904. PubMed ID: 25674262
[TBL] [Abstract][Full Text] [Related]
57. Assessment of tumor cell kinetics by monoclonal antibody Ki-67.
Yonemura Y; Ohoyama S; Kimura H; Kamata T; Yamaguchi A; Miyazaki I
Eur Surg Res; 1990; 22(6):365-70. PubMed ID: 2079097
[TBL] [Abstract][Full Text] [Related]
58. Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.
Gerdes J; Lelle RJ; Pickartz H; Heidenreich W; Schwarting R; Kurtsiefer L; Stauch G; Stein H
J Clin Pathol; 1986 Sep; 39(9):977-80. PubMed ID: 3020096
[TBL] [Abstract][Full Text] [Related]
59. [Ki67 immunohistochemical staining: the present situation of diagnostic criteria].
Hayashi Y; Takei H; Kurosumi M
Nihon Rinsho; 2012 Sep; 70 Suppl 7():428-32. PubMed ID: 23350436
[No Abstract] [Full Text] [Related]
60. [Correlations between metric, cyto and histomorphological factors and thermographic findings in breast neoplasms].
Bothmann GA; Haag D; Wurster K; Rummel HH
Schweiz Med Wochenschr; 1976 Aug; 106(33):1122-7. PubMed ID: 1006236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
